These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


430 related items for PubMed ID: 19568687

  • 41. Protective effect and mechanism of rebamipide on NSAIDs associated small bowel injury.
    Xu N, Zhang C, Jing L, Mou S, Cao X, Yu Z.
    Int Immunopharmacol; 2021 Jan; 90():107136. PubMed ID: 33218942
    [Abstract] [Full Text] [Related]

  • 42. Small-bowel side-effects of non-steroidal anti-inflammatory drugs.
    Aabakken L.
    Eur J Gastroenterol Hepatol; 1999 Apr; 11(4):383-8. PubMed ID: 10321753
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Microbiota Plays a Key Role in Non-Steroidal Anti-Inflammatory Drug-Induced Small Intestinal Damage.
    Otani K, Tanigawa T, Watanabe T, Shimada S, Nadatani Y, Nagami Y, Tanaka F, Kamata N, Yamagami H, Shiba M, Tominaga K, Fujiwara Y, Arakawa T.
    Digestion; 2017 Apr; 95(1):22-28. PubMed ID: 28052268
    [Abstract] [Full Text] [Related]

  • 45. Nonsteroidal anti-inflammatory drug-induced enteropathy: case discussion and review of the literature.
    Kwo PY, Tremaine WJ.
    Mayo Clin Proc; 1995 Jan; 70(1):55-61. PubMed ID: 7808053
    [Abstract] [Full Text] [Related]

  • 46. Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy.
    Fujimori S, Takahashi Y, Gudis K, Seo T, Ehara A, Kobayashi T, Mitsui K, Yonezawa M, Tanaka S, Tatsuguchi A, Sakamoto C.
    J Gastroenterol; 2011 Jan; 46(1):57-64. PubMed ID: 20924615
    [Abstract] [Full Text] [Related]

  • 47. Risk factors of symptomatic NSAID-induced small intestinal injury and diaphragm disease.
    Ishihara M, Ohmiya N, Nakamura M, Funasaka K, Miyahara R, Ohno E, Kawashima H, Itoh A, Hirooka Y, Watanabe O, Ando T, Goto H.
    Aliment Pharmacol Ther; 2014 Sep; 40(5):538-47. PubMed ID: 25041257
    [Abstract] [Full Text] [Related]

  • 48. Nonsteroidal antiinflammatory drugs and the small intestine.
    Fortun PJ, Hawkey CJ.
    Curr Opin Gastroenterol; 2007 Mar; 23(2):134-41. PubMed ID: 17268241
    [Abstract] [Full Text] [Related]

  • 49. Non-steroidal anti-inflammatory drugs-induced small intestinal injury and probiotic agents.
    Guslandi M.
    World J Gastroenterol; 2012 Aug 21; 18(31):4241-2. PubMed ID: 22919262
    [Abstract] [Full Text] [Related]

  • 50. Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?
    Adebayo D, Bjarnason I.
    Postgrad Med J; 2006 Mar 21; 82(965):186-91. PubMed ID: 16517800
    [Abstract] [Full Text] [Related]

  • 51. Aspirin-induced small bowel injuries and the preventive effect of rebamipide.
    Mizukami K, Murakami K, Abe T, Inoue K, Uchida M, Okimoto T, Kodama M, Fujioka T.
    World J Gastroenterol; 2011 Dec 14; 17(46):5117-22. PubMed ID: 22171147
    [Abstract] [Full Text] [Related]

  • 52. Microbial flora in NSAID-induced intestinal damage: a role for antibiotics?
    Lanas A, Scarpignato C.
    Digestion; 2006 Dec 14; 73 Suppl 1():136-50. PubMed ID: 16498262
    [Abstract] [Full Text] [Related]

  • 53. Wireless capsule endoscopy in enteropathy induced by nonsteroidal anti-inflammatory drugs in pigs.
    Tachecí I, Kvetina J, Bures J, Osterreicher J, Kunes M, Pejchal J, Rejchrt S, Spelda S, Kopácová M.
    Dig Dis Sci; 2010 Sep 14; 55(9):2471-7. PubMed ID: 20013311
    [Abstract] [Full Text] [Related]

  • 54. Small intestinal injury in NSAID users suffering from rheumatoid arthritis or osteoarthritis.
    Tachecí I, Bradna P, Douda T, Baštecká D, Kopáčová M, Rejchrt S, Lutonský M, Soukup T, Bureš J.
    Rheumatol Int; 2016 Nov 14; 36(11):1557-1561. PubMed ID: 27549792
    [Abstract] [Full Text] [Related]

  • 55. Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine.
    Smale S, Tibble J, Sigthorsson G, Bjarnason I.
    Best Pract Res Clin Gastroenterol; 2001 Oct 14; 15(5):723-38. PubMed ID: 11566037
    [Abstract] [Full Text] [Related]

  • 56. Anti-tumour necrosis factor agents reduce non-steroidal anti-inflammatory drug-induced small bowel injury in rheumatoid arthritis patients.
    Watanabe T, Tanigawa T, Shiba M, Nadatani Y, Nagami Y, Sugimori S, Yamagami H, Watanabe K, Tominaga K, Fujiwara Y, Koike T, Arakawa T.
    Gut; 2014 Mar 14; 63(3):409-14. PubMed ID: 23697473
    [Abstract] [Full Text] [Related]

  • 57. Small bowel injury in low-dose aspirin users.
    Endo H, Sakai E, Kato T, Umezawa S, Higurashi T, Ohkubo H, Nakajima A.
    J Gastroenterol; 2015 Apr 14; 50(4):378-86. PubMed ID: 25501289
    [Abstract] [Full Text] [Related]

  • 58. [Nonsteroidal anti-inflammatory drug-induced enteropathy and chronic nonspecific multiple ulcers of the small intestine].
    Matsumoto T, Nakamura S, Koga H, Matsui T, Iida M, Yao T.
    Nihon Rinsho; 2008 Jul 14; 66(7):1323-9. PubMed ID: 18616123
    [Abstract] [Full Text] [Related]

  • 59. NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same?
    Fornai M, Antonioli L, Colucci R, Pellegrini C, Giustarini G, Testai L, Martelli A, Matarangasi A, Natale G, Calderone V, Tuccori M, Scarpignato C, Blandizzi C.
    J Pharmacol Exp Ther; 2014 Jan 14; 348(1):86-95. PubMed ID: 24135073
    [Abstract] [Full Text] [Related]

  • 60. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ, Agrawal NM.
    Dig Dis; 1995 Jan 14; 13 Suppl 1():48-61. PubMed ID: 7697902
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 22.